While low-pass sequencing followed by imputation is a powerful tool, use cases such asde novo discovery of variants, or detection of known rare variants, require sequencing at higher depths of coverage. To serve this use case and to help move towards Gencove’s vision of ubiquitous sequencing, we’re happy to announce support for our deep whole genome sequencing (WGS) pipeline!
Learn more about the new pipeline by reading our blog post on Processing deep sequencing data with the Gencove platform.